FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1145491420> ?p ?o ?g. }

• W1145491420 endingPage "592" @default.
• W1145491420 startingPage "581" @default.
• W1145491420 abstract "Bone metastasis remains incurable with treatment restricted to palliative care. Cabozantinib (CBZ) is targeted against multiple receptor tyrosine kinases involved in tumour pathobiology, including hepatocyte growth factor receptor (MET) and vascular endothelial growth factor receptor 2 (VEGFR-2). CBZ has demonstrated clinical activity in advanced prostate cancer with resolution of lesions visible on bone scans, implicating a potential role of the bone microenvironment as a mediator of CBZ effects. We characterised the effects of short-term administration of CBZ on bone in a range of in vivo models to determine how CBZ affects bone in the absence of tumour. Studies were performed in a variety of in vivo models including male and female BALB/c nude mice (age 6–17-weeks). Animals received CBZ (30 mg/kg, 5 × weekly) or sterile H2O control for 5 or 10 days. Effects on bone integrity (μCT), bone cell activity (PINP, TRAP ELISA), osteoblast and osteoclast number/mm trabecular bone surface, area of epiphyseal growth plate cartilage, megakaryocyte numbers and bone marrow composition were assessed. Effects of longer-term treatment (15-day & 6-week administration) were assessed in male NOD/SCID and beige SCID mice. CBZ treatment had significant effects on the bone microenvironment, including reduced osteoclast and increased osteoblast numbers compared to control. Trabecular bone structure was altered after 8 administrations. A significant elongation of the epiphyseal growth plate, in particular the hypertrophic chondrocyte zone, was observed in all CBZ treated animals irrespective of administration schedule. Both male and female BALB/c nude mice had increased megakaryocyte numbers/mm2 tissue after 10-day CBZ treatment, in addition to vascular ectasia, reduced bone marrow cellularity and extravasation of red blood cells into the extra-vascular bone marrow. All CBZ-induced effects were transient and rapidly lost following cessation of treatment. Short-term administration of CBZ induces rapid, reversible effects on the bone microenvironment in vivo highlighting a potential role in mediating treatment responses." @default.
• W1145491420 created "2016-06-24" @default.
• W1145491420 creator A5000212934 @default.
• W1145491420 creator A5000459869 @default.
• W1145491420 creator A5006076513 @default.
• W1145491420 creator A5015609268 @default.
• W1145491420 creator A5016753393 @default.
• W1145491420 creator A5018745405 @default.
• W1145491420 creator A5023495503 @default.
• W1145491420 creator A5044776185 @default.
• W1145491420 creator A5057845341 @default.
• W1145491420 date "2015-12-01" @default.
• W1145491420 modified "2023-10-12" @default.
• W1145491420 title "Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo" @default.
• W1145491420 cites W1490349467 @default.
• W1145491420 cites W1583699618 @default.
• W1145491420 cites W1601100085 @default.
• W1145491420 cites W1608409875 @default.
• W1145491420 cites W1964609210 @default.
• W1145491420 cites W1965801120 @default.
• W1145491420 cites W1969726379 @default.
• W1145491420 cites W1971727102 @default.
• W1145491420 cites W1979055605 @default.
• W1145491420 cites W1980875076 @default.
• W1145491420 cites W1991824786 @default.
• W1145491420 cites W1999619355 @default.
• W1145491420 cites W2000503805 @default.
• W1145491420 cites W2014208932 @default.
• W1145491420 cites W2019744993 @default.
• W1145491420 cites W2020589531 @default.
• W1145491420 cites W2035174231 @default.
• W1145491420 cites W2041019655 @default.
• W1145491420 cites W2042157492 @default.
• W1145491420 cites W2046427955 @default.
• W1145491420 cites W2048299560 @default.
• W1145491420 cites W2050285556 @default.
• W1145491420 cites W2050724276 @default.
• W1145491420 cites W2094554815 @default.
• W1145491420 cites W2100945326 @default.
• W1145491420 cites W2104945673 @default.
• W1145491420 cites W2111807012 @default.
• W1145491420 cites W2113142255 @default.
• W1145491420 cites W2114011767 @default.
• W1145491420 cites W2121562333 @default.
• W1145491420 cites W2122956665 @default.
• W1145491420 cites W2123463315 @default.
• W1145491420 cites W2126765767 @default.
• W1145491420 cites W2127459809 @default.
• W1145491420 cites W2134975411 @default.
• W1145491420 cites W2136390065 @default.
• W1145491420 cites W2144525489 @default.
• W1145491420 cites W2147604626 @default.
• W1145491420 cites W2151005088 @default.
• W1145491420 cites W2151260542 @default.
• W1145491420 cites W2158011521 @default.
• W1145491420 cites W2163751866 @default.
• W1145491420 cites W2165102404 @default.
• W1145491420 cites W2166887772 @default.
• W1145491420 cites W2189161687 @default.
• W1145491420 doi "https://doi.org/10.1016/j.bone.2015.08.003" @default.
• W1145491420 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4768060" @default.
• W1145491420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26279137" @default.
• W1145491420 hasPublicationYear "2015" @default.
• W1145491420 type Work @default.
• W1145491420 sameAs 1145491420 @default.
• W1145491420 citedByCount "34" @default.
• W1145491420 countsByYear W11454914202016 @default.
• W1145491420 countsByYear W11454914202017 @default.
• W1145491420 countsByYear W11454914202018 @default.
• W1145491420 countsByYear W11454914202019 @default.
• W1145491420 countsByYear W11454914202020 @default.
• W1145491420 countsByYear W11454914202021 @default.
• W1145491420 countsByYear W11454914202022 @default.
• W1145491420 countsByYear W11454914202023 @default.
• W1145491420 crossrefType "journal-article" @default.
• W1145491420 hasAuthorship W1145491420A5000212934 @default.
• W1145491420 hasAuthorship W1145491420A5000459869 @default.
• W1145491420 hasAuthorship W1145491420A5006076513 @default.
• W1145491420 hasAuthorship W1145491420A5015609268 @default.
• W1145491420 hasAuthorship W1145491420A5016753393 @default.
• W1145491420 hasAuthorship W1145491420A5018745405 @default.
• W1145491420 hasAuthorship W1145491420A5023495503 @default.
• W1145491420 hasAuthorship W1145491420A5044776185 @default.
• W1145491420 hasAuthorship W1145491420A5057845341 @default.
• W1145491420 hasBestOaLocation W11454914201 @default.
• W1145491420 hasConcept C121608353 @default.
• W1145491420 hasConcept C126322002 @default.
• W1145491420 hasConcept C134018914 @default.
• W1145491420 hasConcept C150903083 @default.
• W1145491420 hasConcept C170493617 @default.
• W1145491420 hasConcept C185592680 @default.
• W1145491420 hasConcept C202751555 @default.
• W1145491420 hasConcept C207001950 @default.
• W1145491420 hasConcept C2776033226 @default.
• W1145491420 hasConcept C2777783956 @default.
• W1145491420 hasConcept C2778260815 @default.
• W1145491420 hasConcept C2779013556 @default.
• W1145491420 hasConcept C2780007613 @default.

• next